The Early Treatment Diabetic Retinopathy Study (ETDRS) alphabet chart is not feasible for measuring best-corrected visual acuity (BCVA) for individuals who are unfamiliar with the Roman alphabet. The ETDRS Landolt C chart is an alternative, but it may not reflect true BCVA among those with confusion between left and right. The ETDRS number chart might overcome these limitations, but little is known regarding its reliability.
arly Treatment Diabetic Retinopathy Study (ETDRS) visual acuity (VA) charts, modified from Bailey-Lovie charts, are often used to measure best-corrected VA (BCVA) owing to their high repeatability and accuracy. [1] [2] [3] [4] However, these charts cannot be used in individuals who are unfamiliar with Roman alphabets. The ETDRS Landolt C chart, Tumbling E chart, and automated Landolt C chart are alternatives with proven repeatability and agreement [5] [6] [7] [8] ; however, they may not reflect true BCVA in individuals with confusion between left and right. 9 An ETDRS number chart is available, but, to our knowledge, its repeatability and agreement with the alphabet ETDRS chart is unknown. Therefore, we evaluated the repeatability and agreement of BCVA using ETDRS number charts and ETDRS Landolt C charts compared with ETDRS alphabet charts in eyes with normal and reduced VA.
Methods
This cross-sectional study was conducted at Chiang Mai University Hospital, Chiang Mai, Thailand, from July 1, 2015, to June 30, 2016. Adult Thai volunteers with at least a secondary school education who passed a screening test of the Roman alphabet were invited to participate. At screening, BCVA measurements were performed following a standardized refraction protocol, with only 1 study eye per participant, followed by a complete eye examination. If both eyes were eligible, the right eye was the study eye. The study was approved by the Research Ethics Committee, Faculty of Medicine, Chiang Mai University, and adhered to the tenets of the Declaration of Helsinki. 10 Written informed consent was obtained from each study participant. Participants were classified into the following 4 groups: group A, which comprised 60 healthy eyes with normal vision (BCVA, 20/20-20/25); group B, which comprised 40 eyes with pathologic findings not judged clinically relevant due to age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/20-20/40); group C, which comprised 40 diseased eyes due to age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/50-20/100); and group D, which comprised 14 diseased eyes due to age-related cataract, diabetic macular edema, or age-related macular degeneration (BCVA, 20/125-20/200). Eyes with age-related cataract, diabetic macular edema, or agerelated macular degeneration were recruited in a ratio of 2:1:1 for groups B, C, and D.
Participants underwent standardized 4-m BCVA measurements after standardized refraction using 3 types of ETDRS charts (Precision Vision), including a PV number chart (No. 2702A), Landolt C chart (No. 2210), and Roman alphabet chart (No. 2111), in 2 rounds in random sequence, with at least 30 minutes between the first and second round and at least 2 minutes between charts. Participants were asked to read as many optotypes as possible. They either stopped reading when they could not read anymore, or the technician asked them to stop when they made 5 incorrect answers in a row. Each optotype of each chart could be read only once. The 3 chart measurements were performed and recorded by a single technician in the same testing room with similar lighting conditions. The ETDRS letter scores and testing durations of each participant were recorded.
Repeatability between the first and second round of each ETDRS chart among participants with impaired VA and those in group A was measured by Pearson correlation coefficients. Agreement among the 3 types of charts was assessed using intraclass correlation coefficients, which were compared using the F test. Owing to dependency and nonnormal distribution of the letter scores, differences in letter scores between charts were compared using Wilcoxon signed rank tests. Differences in testing duration were explored using the Friedman test. All statistical analyses were performed in R, version 3.2.4 (R Foundation for Statistical Computing). P values were 2-sided. No P value was considered statistically significant as there was no a priori correction for multiple analyses. 
Results

Repeatability
The ETDRS number chart repeatability coefficients were 0.61 (95% CI, 0.42-0.75) for group A, 0.87 (95% CI, 0.78-0.93) for group B, 0.81 (95% CI, 0.67-0.90) for group C, and 0.81 (95% CI, 0.49-0.94) for group D. The ETDRS Landolt C chart and ETDRS alphabet chart had strong repeatability coefficients ( Table 1) .
Agreement With Alphabet Chart
Concordance correlation coefficients between the ETDRS number and alphabet charts were strong (group A, 0. Negative sign indicated that the ETDRS letter scores were less than those measured with the alphabet chart.
c P values for the differences in agreement (intraclass correlation coefficients) were calculated using the F test, and the P values for the differences in letter scores across charts were calculated using the Wilcoxon signed rank test. Negative sign indicated that the ETDRS letter scores were less than those measured with the alphabet chart.
c P values for the differences in agreement (intraclass correlation coefficients) were calculated using the F test, and the P values for the differences in letter scores across charts were calculated using the Wilcoxon signed rank test.
Research Brief Report Agreement of Visual Acuity Using ETDRS Number Charts, Landolt C Charts, or Alphabet Charts . Agreement between number and alphabet charts was higher than agreement between the Landolt C and alphabet charts in all ocular conditions and all VA subgroups but group D ( Table 2 and  Table 3 ). Overall, the mean VA difference between the number and alphabet charts (1 letter [95% limits of agreement, −4 to +6 letters]) was smaller than the mean difference between the Landolt C and alphabet charts (−7 letters [95% limits of agreement, −18 to +5 letters]; P < .001) (Figure) .
Testing Duration
In group A, the testing duration with the Landolt C chart was 1.6 times longer than with the alphabet chart and 2 times longer than with the number chart. In groups B through D, on average, the testing duration with the Landolt C chart was 1.6 times longer than with the alphabet chart and 1.7 times longer than with the number chart ( Table 4) .
Discussion
These results suggest that commercially available ETDRS number charts (PV number Precision Vision chart) provide high repeatability coefficients and excellent agreement with ETDRS alphabet charts. For the ETDRS Landolt C and alphabet charts, although this study found excellent agreement as previously reported, [5] [6] [7] [8] Visual acuity scores obtained from these 2 charts might be pooled in future trials, and some adjustment of VA scores obtained from the ETDRS Landolt C chart (eg, 7 letters) might be needed for pooled analyses.
The longer testing duration with the Landolt C chart was consistent with a previous report. 6 Testing duration with number charts was the shortest, perhaps owing to the design of number optotypes, which are relatively easier to identify compared with the Sloan letter chart or Landolt C chart, or owing to familiarity of number charts among Thai individuals because Snellen charts with number optotypes are used widely in Thailand.
Limitations
This study has some limitations, including the small number of participants in group D. Also, number chart results might be different among individuals who are not familiar with alphabet charts.
Conclusions
These results suggest that the ETDRS number chart gives high repeatability and very good agreement with the original ETDRS alphabet chart. Compared with the ETDRS Landolt C chart, the ETDRS number chart provided better agreement with the ETDRS alphabet chart with shorter testing duration in those with or without VA loss. These findings suggest that the ET-DRS number chart can measure VA reliably in clinical trials, including regions in which most people are not familiar with the Roman alphabet. However, for illiterate individuals, the Landolt C chart may still be used to measure VA. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
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